[Disorders of body water regulation and the therapy--role of atrial natriuretic peptide in homeostasis of body water in heart failure].
Knoshita
M
M
Wada
A
A
D057911:Angiotensin Receptor Antagonists; D000818:Animals; D009320:Atrial Natriuretic Factor / Q000502:physiology*; D001381:Azepines / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds / Q000627:therapeutic use; D001834:Body Water / Q000378:metabolism*; D015536:Down-Regulation; D065128:Endothelin Receptor Antagonists; D006333:Heart Failure / Q000188:drug therapy / Q000503:physiopathology*; D006706:Homeostasis; D006801:Humans; D007211:Indoles / Q000627:therapeutic use; D010456:Peptides, Cyclic / Q000627:therapeutic use; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D017461:Receptors, Atrial Natriuretic Factor / Q000378:metabolism; D012964:Sodium / Q000378:metabolism*; D013777:Tetrazoles
D057911:Angiotensin Receptor Antagonists; D001381:Azepines; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D065128:Endothelin Receptor Antagonists; D007211:Indoles; D010456:Peptides, Cyclic; D044022:Receptor, Endothelin A; D044023:Receptor, Endothelin B; D013777:Tetrazoles; C079574:FR 139317; C087120:RES 701-1; D009320:Atrial Natriuretic Factor; D012964:Sodium; D017461:Receptors, Atrial Natriuretic Factor; C077793:candesartan cilexetil